Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer

Figure 7 Forest plot of univariate competing risk models with time-dependent covariate. Higher risk of disease-specific mortality was associated with a lower lymphocyte-to-monocyte ratio, hemoglobin-to-platelet ratio, and platelet-to-lymphocyte ratio, and higher red blood cell distribution width-to-platelet ratio, personalized platelet count relative to “at-diagnosis”, and personalized platelet count relative to “after-surgery”. Neutrophil-to-lymphocyte ratio did not affect disease-specific mortality of study participants. CI: Confidence interval; HR: Hazard ratio. LMR: Lymphocyte-to-monocyte ratio; PLR: Platelet-to-lymphocyte ratio; NLR: Neutrophil-to-lymphocyte ratio; HPR: hemoglobin-to-platelet ratio; RPR: red blood cell distribution width-to-platelet ratio; pPLT_D: Personalized platelet count relative to “at-diagnosis”; pPLT_S: Personalized platelet count relative to “after-surgery”.